Triethylenemelamine
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 2,4,6-Tris(aziridin-1-yl)-1,3,5-triazine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 51-18-3 |
| ATC code | ? |
| PubChem | CID 5799 |
| UNII | F7IY6HZG9D |
| KEGG | C07642 |
| ChEMBL | CHEMBL502384 |
| Chemical data | |
| Formula | C9H12N6 |
| Mol. mass | 204.23 g/mol |
| |
|
Triethylenemelamine is a drug used in chemotherapy.
It can cause chromatid aberrations.[1]
[edit] See also
[edit] References
- ^ Luippold HE, Gooch PC, Brewen JG (February 1978). "The production of chromosome aberrations in various mammalian cells by triethylenemelamine". Genetics 88 (2): 317–26. PMC 1213803. PMID 565312. http://www.genetics.org/cgi/pmidlookup?view=long&pmid=565312.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |